General Announcement::ASX:TLX; Nasdaq: TLX - Telix H1 2025 Appendix 4D and Interim Report

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
21-Aug-2025 06:30:45
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq: TLX - Telix H1 2025 Appendix 4D and Interim Report
Announcement Reference
SG250821OTHREODE
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
21/08/2025 10:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq: TLX - Telix H1 2025 Appendix 4D and Interim Report

Attachments

20250821 H1 2025 Appendix 4D and Interim Report vFINAL.pdf
Total size =2254K